RITSUKO KOMAKI to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Randomized Controlled Trials as Topic.
Connection Strength
0.242
-
Is prophylactic cranial irradiation indicated for patients with extensive-stage small cell lung cancer with a complete response to first-line treatment? Radiother Oncol. 2018 06; 127(3):339-343.
Score: 0.085
-
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. J Clin Oncol. 2011 Jun 20; 29(18):2590-7.
Score: 0.053
-
What should the optimal timing be for amifostine administration relative to radiation and chemotherapy? J Clin Oncol. 2005 Oct 01; 23(28):7232-3; author reply 7233-5.
Score: 0.036
-
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials. JAMA Netw Open. 2023 04 03; 6(4):e238504.
Score: 0.030
-
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. Cochrane Database Syst Rev. 2015 Mar 02; (3):CD011430.
Score: 0.017
-
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol. 2009 Dec 01; 27(34):5816-22.
Score: 0.012
-
Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):111-8.
Score: 0.010